The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.

A federal judge on Tuesday afternoon temporarily blocked part of the Trump administration’s plans to freeze all federal aid, ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...

Republican lawmakers are floating a range of ideas to pay for an extension of President Trump's Tax Cuts and Jobs Act.

Medicare, the national health program for nearly all Americans 65 and older, was created in 1965. As the program evolves, ...

The Centers for Medicare and Medicaid Services (CMS) listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top of its list of drugs selected for Medicare negotiation in 2025.

Publication of the list kicks off a monthslong process that will feature a series of meetings between drugmakers and the CMS, which oversees the Medicare ... Health plan sponsors that contract ...

Medicare officials announced plans to negotiate the prices of blockbuster ... The drugs are on a list of 15 whose prices will be negotiated this year in a program created by one of President ...